Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes-Reference-Cited by-同舟云学术

Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes

Published:2023-03-01 Issue:5 Volume:62 Page:681-688
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Iijima Yasuhiro¹,Nakayama Masafumi²,Miwa Takashi³,Yakou Fumiyoshi¹,Tomiyama Hirofumi⁴,Shikuma Junpei³,Ito Rokuro³,Tanaka Akihiko¹,Manda Naoki⁵,Odawara Masato³

Affiliation:

1. Department of Internal Medicine, Todachuo General Hospital, Japan

2. Cardiovascular Center, Todachuo General Hospital, Japan

3. Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hospital, Japan

4. Department of Cardiology, Tokyo Medical University Hospital, Japan

5. Diabetes Center, Manda Memorial Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/5/62_6685-20/_pdf

Reference37 articles.

1. 1. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting plasma glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375: 2215-2222, 2010.

2. 2. Cheung N, Wang JJ, Klein R, et al. Diabetic retinopathy and the risk of coronary heart disease: the atherosclerosis risk in communities study. Diabetes Care 30: 1742-1746, 2007.

3. 3. Patel A, MacMahon S, Chalmers J, et al. Intensive plasma glucose control and vascular outcomes in subjects with type 2 diabetes. N Engl J Med 358: 2560-2572, 2008.

4. 4. de Boer IH, Rue TC, Hall YN, et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 305: 2532-2539, 2011.

5. 5. Papademetriou V, Lovato L, Doumas M, et al. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in subjects with type 2 diabetes. Kidney Int 87: 649-659, 2015.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of dapagliflozin on metabolic disorders, β islets cell function and serum protein expressions in patients with type 2 diabetes mellitus;Tropical Journal of Pharmaceutical Research;2024-04-14